Loading...
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
Hepatocellular carcinoma (HCC) represents ~90% of primary liver cancers and constitutes a major global health problem. Since a decade ago, the management of advanced disease that cannot be locally treated has mainly been based on multi-targeted antiangiogenic therapies. Some have demonstrated improv...
Saved in:
| Published in: | J Hepatocell Carcinoma |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Review
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6219272/ https://ncbi.nlm.nih.gov/pubmed/30464931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S157413 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|